Results 111 to 120 of about 8,840 (216)

Association between the concentration of IP-10 produced by BMECs after NMOSD sera and clinical phenotypes/clinical courses/CSF parameter in NMOSD patients.

, 2015
(A) The IP-10 protein levels produced by the cells in the acute NMOSD group were significantly increased compared to that observed in the RRMS, stable NMO and HC groups using another specified ELISA assay. (B) The IP-10 protein levels in the cells in the
Fumitaka Shimizu (545145), Toshihiko Maeda (702834), Masaaki Abe (202786), Yasuteru Sano (545147), Michiaki Koga (60773), Shiori Takahashi (712800), Takashi Kanda (545152), Yukio Takeshita (702833), Toshiyuki Takahashi (37431), Hideaki Nishihara (545149)   +9 more
core   +1 more source

Hypersomnia in Neuromyelitis Optica Spectrum Disorders

Türk Uyku Tıbbı Dergisi
Hypersomnolence or narcolepsy may be the initial finding in neuromyelitis optica spectrum disorders (NMOSD); therefore, it is important in clinical evaluation.
Hasan Can Güdek, Özdem Ertürk Çetin, İpek Güngör Doğan, Damla Çetinkaya Tezer, Serkan Demir   +4 more
doaj   +1 more source

Identification of new NMOSD and MOGAD genetic associations

, 2023
International audienceIntroduction: Neuromyelitis Optica Spectrum Disorder (NMOSD) is a severe autoimmune demyelinating disease of the optic nerves and spinal cord affecting 0.4-4/100,000 individuals worldwide.
Bourre, Bertrand, Marignier, Romain, Zéphyr, Thi Hélène, Collongues, Nicolas, Vince, Nicolas, Charles, Irène, Cohen, Mikael, Maillart, Elisabeth, Ayrignac, Xavier, Vukusic, Sandra, Papeix, Caroline, Gourraud, Pierre-Antoine, Bourguiba-Hachemi, Sonia, Banyahya, Lakhdar, Deschamps, Romain, Cotton, François, Durand-Dubief, Françoise, Limou, Sophie, Ruet, Aurélie, Thouvenot, Eric, Audoin, Bertrand, Ciron, Jonathan, Laplaud, David‐axel   +22 more
core  

Inflammatory and Nutritional Markers as Indicators for Diagnosing and Assessing Disease Activity in MS and NMOSD

Journal of Inflammation Research
Xiaotong Li,1– 3,* Wencan Jiang,1– 3,* Guoge Li,1– 3 Yaowei Ding,1– 3 Haoran Li,1– 3 Jialu Sun,1– 3 Yuxin Chen,1– 3 Siqi Wang,1– 3 Guojun Zhang1– 3 1Department of Clinical Diagnosis, Laboratory of Beijing Tiantan Hospital, Capital Medical ...
Li X, Jiang W, Li G, Ding Y, Li H, Sun J, Chen Y, Wang S, Zhang G   +8 more
doaj  

Neuromyelitis optica spectrum disorder overlapping with Sjögren's disease: immunopathological links and therapeutic implications. [PDF]

Front Immunol
Xu W, Xing H, Hou L.
europepmc   +1 more source

Multimodal MRI biomarkers and machine learning in neuromyelitis optica spectrum disorder: a review. [PDF]

Front Neurol
Zhang J, Xu H, Zhao M, Zheng Z, Zhao Y.
europepmc   +1 more source

Functional and effective connectivity alterations relate to cognitive performance in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder. [PDF]

Brain Commun
Leveraro E, Cipriano E, Lombardi G, Currò D, Tazza F, Novi G, Laroni A, Gazzola P, Malentacchi M, Petrucci L, Lapucci C, Inglese M.   +11 more
europepmc   +1 more source

Plasmapheresis for NMOSD: Not a rescue therapy anymore!?

Annals of Indian Academy of Neurology, 2019
Rohit Bhatia, Radhakrishna Pedapati, Siddharth Chopra   +2 more
openaire   +3 more sources

De-Escalating and Discontinuing Immunotherapies in Patients With NMOSD and MOGAD. [PDF]

Neurology
Hacohen Y, Androdias G, Arrambide G, Bruijstens AL, Ciccarelli O, Cobo-Calvo A, Flanagan EP, Kim HJ, Iacobaeus E, Lünemann JD, Stankoff B, Tintore M, Marignier R.   +12 more
europepmc   +1 more source

What's new in NMOSD and MOGAD?

Revue Neurologique
In this mini-review, we focus on novelties in the field of neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD). We first describe the proposed criteria for MOGAD and evaluate their impact and potential limitations, with a highlight on the subgroups of patients tested MOG-antibody ...
openaire   +2 more sources